baber/WOPTO huggingface dataset:
Patent NZ-540575-A (NZ)
Title: Spirocyclic cyclohexane derivatives
Inventor: HINZE CLAUDIA
IPC: A61P25/00
Filed: 2003-11-05
Abstract: Disclosed is a compound of formula I, wherein W is NR4, O or S, X is O, S, SO, SO2 or NR17, and the remaining substituents are as defined in the specification. The compounds show good binding to the ORL1 receptor and are useful in the treatment of pain.
Patent NZ-541665-A (NZ)
Title: Apparatus and method for heat sealing a lidding sheet
Inventor: HOUZEGO PETER JOHN
IPC: B65B7/28
Filed: 2004-02-05
Abstract: An apparatus and method for heat sealing a lidding sheet to a base, wherein the apparatus including a press for pressing a lidding sheet onto a sealing surface of a base, the press including a relatively flexible face plate and the apparatus further including a system for applying pressure to the lidding sheet with the face plate, the face plate flexing to conform to the lidding sheet and the underlying profile of the sealing surface of the base.
Patent NZ-545906-A (NZ)
Title: Functional transition metal silicates (FTMS) for controlling microbes such as plant pathogens
Inventor: PRASAD YANDAPALLI DURGA
IPC: A01N59/16
Filed: 2003-05-15
Abstract: A method for controlling microbes (not including microbes located in or on the human body) is disclosed, wherein the method comprises the step of contacting the microbe with functional transition metal silicate characterized in that the said transition metal silicate is selected from the group comprising: a. Cupric silicates having silica to copper ratio in the range of 1:0.34 to 1:5.15; b. Zinc silicates having silica to zinc ratio in the range of 1: 2 to 1: 12; c. Silver silicates having silica to silver ratio in the range of 1: 15 to 1 : 19.5; d. Manganese silicates having silica to manganese ratio in the range of 1 : 1 to 1 : 1.9; and e. Zirconium silicates having silica to zirconium ratio in the range of 1 : 0.77 to 1 : 2.9, the said transition metal silicates are prepared by the process comprising the steps of: (i) adding a transitional metal salt solution to a soluble alkali silicate solution to form a mixture; (ii) forming a precipitate of a transitional metal silicate, and (iii)washing and drying the precipitate thus formed to obtain the transitional metal silicate, wherein in said step (i), the ratio between the transitional metal salt solution to the alkali silicate solution is varied, the temperature at which the solutions are mixed is varied between 20 to 90 Deg C, and the pH value of the medium is varied between about 2 to about 11. The disclosure also relates to a functional transition metal silicate (FTMS) effective as a decontaminant, a disinfectant, a detoxificant, a protectant, a microbicide or combination thereof, comprising a ratio of transition metal to silica in the transition metal silicate in a predetermined range and a structural composition for said effectiveness, said FTMS being capable of being immobilized on a suitable materials or incorporating into resins and / or coating along with resins on suitable materials.
Patent NZ-547521-A (NZ)
Title: Protein NMB0928 and use thereof in pharmaceutical formulations
Inventor: PAJON FEYT ROLANDO
IPC: C07K16/30
Filed: 2004-12-02
Abstract: Provided is a vaccine composition comprising the protein NMB0928 and wherein said vaccine generates a protective response in the receipt organism against infections caused by bacteria from the Neisseria genus. Further provided is the use of the composition for the preparation of a pharmaceutical composition for the treatment in the human of the infections caused by bacteria from the Neisseria genus.
Patent NZ-548982-A (NZ)
Title: Medical suturing tool
Inventor: ABE KAZUHIRO
IPC: A61B17/04
Filed: 2005-03-02
Abstract: A medical suturing tool is disclosed which comprises of an insertion puncture needle 13 having an insertion hole, a retrieval puncture needle 14 disposed in parallel with the insertion puncture needle 13, a lock part 15, and a surgical suture. A vertically elongated opening 18 is formed on the side surface of the insertion puncture needle 13, and an engaging groove 19 has a wide upper portion 19a and a narrow lower portion 19b on the side surface of the retrieval puncture needle 14 at a position slightly lower than the portion opposing to the vertically elongated opening 18. The lock part 15 is composed of a spherical portion 15a which can pass through a wide upper portion 18a and cannot pass through a narrow lower portion 18b and a rod-shaped portion 15b which can pass through the narrow lower portion 18b.
Patent NZ-552245-A (NZ)
Title: Methods of controlling molluscs with a material containing at least 49% corn cob
Inventor: GRECH NIGEL
IPC: A01N25/00
Filed: 2005-06-08
Abstract: Disclosed is a material for controlling molluscs, wherein said material does not include a conventional molluscicide but comprises a mixture of: (a) at least about 49% crushed corn cob; and (b) a structural carbohydrate selected from hay, straw, seed husks, seed chaff, coconut coir fiber, sisal fiber, coconut shells, nut shells, cotton fibers, cereal seed chaff, legume seed pods, sugar cane bagasse, or combinations thereof. It is also disclosed that the above material may further contain other materials such as attractants (selected from molasses, maple sugar, cottonseed meal, anise, garlic, nutmeg, liquorice, vanilla, synthetic and natural flavouring agents, cane syrup, corn syrup, oils, gypsum, lime, fats, proteins, carbohydrates, alginates, gums, malt sugar, beet molasses, cane molasses, honey, bone meal, beer, ales, chocolate, peanut butter, nuts, shrimp, fish, blood plasma, blood meal, milk, or combinations thereof), simple mineral salts, simple organic salts, or combinations thereof, and simple naturally occurring substances (such as kaolinite, gypsum, borates, silicates, diamataceous earth, plant extracts, or combinations thereof). Also disclosed is a method of inducing death and / or disrupting natural metabolic processes in a mollusc, the method comprising exposing the mollusc to a material as defined above.
Patent NZ-562745-A (NZ)
Title: Oxidisable lipid encapsulated in a complex of casein and whey protein
Inventor: SINGH HARJINDER
IPC: A23D7/06
Filed: 2006-04-26
Abstract: Disclosed is an emulsion comprising at least one oxidisable lipid (such as fish oil, a polyunsaturated fatty acid or ester thereof, or an omega-3 fatty acid such as docosahexaenoic acid or eicosapentaenoic acid) encapsulated in a complex of casein and whey protein, wherein the complex can be formed by heating a mixture of casein and whey protein solutions at about 70OC to about 100OC. Also disclosed is a method of making an emulsion comprising at least one oxidisable lipid encapsulated by a complex of casein and whey protein, the method comprising: (a) heating an aqueous solution of casein and whey protein to form a protein complex (b) dispersing the at least one oxidisable lipid in the aqueous solution, and (c) homogenising the mixture formed in step (b).
Patent NZ-567197-A (NZ)
Title: Rotary cutter device with integrated cooling system
Inventor: SHINN RICKEY D
Filed: 2008-04-04
Abstract: A hydraulic cutter device incorporates a rotatable base including a plurality of spaced cutter teeth. A protective shield covers at least a portion of the base. A fluid cooler is located adjacent the protective shield, and defines a window for movement of ambient air from a relatively high-pressure area upstream of the fluid cooler to a relatively low-pressure area downstream of the fluid cooler. A hydraulic motor is adapted for rotating the base, and includes a plurality of hydraulic lines communicating with the fluid cooler. Rotation of the base creates a pressure reduction downstream of the fluid cooler causing ambient air flow into and through the fluid cooler to cool fluid moving into and from the hydraulic motor.
Patent NZ-570614-A (NZ)
Title: Multipotent adult progenitor cell treatment of brain injuries and diseases
Inventor: MAYS ROBERT W
IPC: A61K35/545
Filed: 2007-01-23
Abstract: The use of multipotent adult stems cells for treating a brain injury. The cells are not embryonic stem cells, embryonic germ cells or germ cells but can differentiate into at least one cell type from the endodermal, ectodermal and mesodermal embryonic lineages. The cells express telomerase and oct3/4 and are of allogenic or xenogenic origin. The cells are not used with an immunosuppressant or with an immunosuppressive therapy. The brain injury can be hypoxic ischemic brain injury, cortical infarction or stroke.
Patent NZ-573073-A (NZ)
Title: Novel epsp synthase genes conferring herbicide resistance
Inventor: CARR BRIAN
IPC: C12N9/10
Filed: 2007-06-08
Abstract: Disclosed is an isolated or recombinant nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of: a) the nucleotide sequence of SEQ ID NOS: 13 or 28, or a complement thereof; b) a nucleotide sequence having at least 90% sequence identity to the nucleotide sequence of SEQ ID NOS: 13 or 28, or a complement thereof, wherein the polypeptide encoded by said nucleic acid molecule has glyphosate resistance activity; c) the herbicide resistance nucleotide sequence of the DNA insert of the plasmid deposited as Accession No. NRRL B-30917, or a complement thereof; d) a nucleotide sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14; and e) a nucleotide sequence encoding a polypeptide having at least 90% amino acid sequence identity to the amino acid sequence of SEQ ID NO:14, wherein said polypeptide has glyphosate resistance activity. Also disclosed are methods of using the nucleotides for conferring herbicide resistance or tolerance to bacteria, plants, plant cells, tissues and seeds
Patent NZ-573169-A (NZ)
Title: Systems and methods for witness card analysis
Inventor: ARMSTRONG WAYNE THOMAS
IPC: G01M13/00
Filed: 2008-11-27
Abstract: A method of assessing a spray using image processing techniques to analyze an image of an as-sprayed witness card 500, the witness card 500 having been sprayed with drops of a fluid, the method comprising preparing a calibration witness card 500 having a plurality of stains, wherein each stain is created with a known volume of a fluid, obtaining an as-sprayed witness card 500, wherein the as-sprayed witness card 500 includes a pattern of stains of the fluid, exposing the calibration witness card 500 to a backlight 625 sufficient to make the plurality of stains visible and, at the same time, capturing an image of the plurality of stains thereon, developing a calibration equation that is based on respective dimensions of the plurality of stains and known volume of the fluid for each stain, exposing the as-sprayed witness card 500 to a backlight 625 sufficient to make the pattern of stains thereon visible and, at the same time, capturing an image of the pattern of stains thereon, and processing the image of the pattern of stains on the as-sprayed witness card 500 using the calibration equation to assess characteristics of the stains of the fluid on the as-sprayed witness card 500 and thereby assess characteristics of the spray.
Patent NZ-577467-A (NZ)
Title: Combination of pemirolast and a statin for use in the treatment of inflammatory disorders
Inventor: RAUD JOHAN
IPC: A61K31/366
Filed: 2007-11-16
Abstract: A combination or kit thereof comprising (A) pemirolast and (b) a statin selected from rosuvastatin and atorvastatin. The combination can be used to treat inflammatory conditions in particular: migraine, asthma, chronic obstructive pulmonary disease, Crohn's disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ulcerative cololitis or a cardiovascular disease. In particular the cardiovascular disease is atherosclerosis or an associated disorder selected from aortic aneurysm, arteriosclerosis, peripheral arterial occlusive disease, a coronary artery disease, a coronary disease, plaque rupture, atheroma rupture, vascular disease, arterial disease, ischemic disease, ischemia and stroke.
Patent NZ-584979-A (NZ)
Title: Peptide inhibiting angiotensin converting enzyme
Inventor: TONOUCHI HIDEKAZU
IPC: C07K7/06
Filed: 2004-12-01
Abstract: Provided is the tri-peptide Ile-His-Ala for inhibiting an angiotensin-converting enzyme to prevent and/or treat hypertension or diseases caused by hypertension.
Patent NZ-590353-A (NZ)
Title: Patient lift with hanger bar attachment
Inventor: CHAPMAN KENNETH
IPC: A61G7/10
Filed: 2009-07-10
Abstract: 590353 Disclosed is a patient lift apparatus. The apparatus has a frame portion, a boom portion connected to the frame portion, a hanger assembly connected to the boom portion, and a hanger bar attachment support providing a support surface of the boom portion. The hanger bar attachment support has a first and second housing parts adapted to be selectively connected to one another to form a housing. One of the first and second housing parts of the hanger bar attachment support can be removed to allow access to an interior of the hanger bar attachment support thereby permitting the hanger assembly to be selectively connected or disconnected from the boom portion. The other of the first and second housing parts remains attached to the boom portion so as to provide the support surface of the boom portion.
Patent NZ-591358-A (NZ)
Title: Process for the preparation of ethanedinitrile
Inventor: KLEGRAF ELLEN
IPC: C01C3/00
Filed: 2009-11-09
Abstract: Disclosed is a process for the preparation of ethanedinitrile (cyanogen) in liquid phase, by catalytic oxidation of hydrocyanic acid in the presence of a cupric ion catalyst and an aprtic polar solvent, wherein the nitric acid is added as a sole oxidant to the reaction mixture. Further disclosed is ethanedinitrile in liquid phase prepared by the process described within the specification.
Patent NZ-596919-A (NZ)
Title: Beverage cartridge with filter guard
Inventor: BEAULIEU RODERICK H
IPC: A47J31/44
Filed: 2010-05-26
Abstract: 596919 A cartridge (10) for forming a beverage includes a container (12) defining an interior space (14), a filter (30), a beverage medium (20) contained in the interior space, and a filter guard (40). The filter (30) may be arranged so that liquid that interacts with the beverage medium flows through the filter to exit the interior space. The container includes a surface arranged to be pierced by a piercing member (52) to permit beverage to exit the container. The filter guard (40) is arranged to contact the piercing member (52) to resist damage to the filter when the container surface is pierced by a piercing member (52). The filter guard is positioned between the bottom of the container and the filter. A portion of the filter is displaceable relative to the container. The filter guard is arranged to move within the interior space of the container away from the bottom upon contact with the piercing element to displace at least a portion of the filter. In one embodiment, the filter guard (40) and filter (30) may be in contact with the container surface that is pierced, but due to the filter guard damage that might be caused by the piercing element may be avoided.
Patent NZ-597115-A (NZ)
Title: Method of treating age related disorders with fujimycin
Inventor: MELLOR ELIZABETH JANE
IPC: A61K31/436
Filed: 2010-07-08
Abstract: Disclosed is the use of fujimycin in the manufacture of a medicament for the treatment of a disorder related to the chronological and/or replicative life-span of a cell, said disorder selected from the group comprising a diabetes type 1, diabetes type 2, artherosclerosis, sarcopenia, cachexia and osteoporosis.
Patent NZ-597322-A (NZ)
Title: Elastomeric vortex generators
Inventor: IRELAND PETER S
IPC: B63B1/36
Filed: 2010-07-09
Abstract: A method of improving aerodynamic performance of foils by the application of conformal, elastomeric vortex generators. The use of elastomers allows the application of various forms of vortex generators to sections that have been problematic from engineering and cost considerations. A vortex generator profile is identified, which develops an additional co-rotating vortex at low energy expenditure. The mechanisms allow for the application of transverse vortex generators, or Gurney Flaps/Lift Enhancement Tabs/Divergent Trailing Edges, to propellers, rotor blades, and to wings/flaps/ control trailing edges. Cove Tabs are additionally described using an elastomeric transverse vortex generator to achieve performance improvements of a high lift device. The VG is characterised in that it is configured to conform to the aero/hydrodynamic surface across substantially the entire extent of the extrusion or section.
Patent NZ-599914-A (NZ)
Title: Selective heterocyclic sphingosine 1 phosphate receptor modulators
Inventor: BOEHM MARCUS F
IPC: A01N43/78
Filed: 2010-11-15
Abstract: Disclosed herein is a compound of Formula (I) wherein the variable are defined in the specification; the use thereof in the treatment of multiple sclerosis, translplant rejection or acute respiratory distress syndrome by activation or agonism of a sphingosine-1-phosphate receptor subtype 1; and a method for the preparation thereof. In one embodiment the compound is 5-(5-(1-hydroxy-2,3-dihydro-1H-inden-4-yl)thiophen-3-yl)-2-isopropoxybenzonitrile.
Patent NZ-600511-A (NZ)
Title: Neutralizing prolactin receptor antibodies and their therapeutic use
Inventor: EICKER ANDREA
IPC: A61P5/08
Filed: 2010-11-18
Abstract: Disclosed is the neutralizing prolactin receptor antibody 006- H08, as well as maturated forms thereof, and antigen-binding fragments, pharmaceutical compositions containing them and their use in the treatment or prevention of benign disorders and indications mediated by the prolactin receptor such as endometriosis, adenomyosis, non-hormonal female contraception, benign breast disease and mastalgia, lactation inhibition, benign prostate hyperplasia, fibroids, hyper- and normoprolactinemic hair loss, and cotreatment in combined hormone therapy to inhibit mammary epithelial cell proliferation. The antibodies of the invention block prolactin receptor-mediated signaling.
Patent NZ-608287-A (NZ)
Title: Cladding rail, cladding fixing system and method
Inventor: LUKASZEWICZ JOHN WITOLD
IPC: E04F19/06
Filed: 2010-10-28
Abstract: A mounting rail for mounting a cladding panel in flush formation is disclosed. The mounting rail includes an elongate body shaped in cross section (121) having a vertical leg (125) adapted to be attached to the wall, an upper throat (128) for the location and support of an upper panel by a lower panel portion bead member (123) and a lower throat (131) for a lower panel to be located and supported by an upper panel portion bead member (122). The system provides flush mounted panels having a horizontal gap between with no fastening on an outer face of the panels.
Patent NZ-613788-A (NZ)
Title: Analyte detection devices, multiplex and tabletop devices for detection of analytes, and uses thereof
Inventor: SICILIANO NICHOLAS A
IPC: G01N33/543
Filed: 2012-01-27
Abstract: 613788 A device for detecting an analyte, particularly for detecting food borne pathogens. The device has a force actuator (3200); a force release (3000); an analyte detection membrane system; an analyte detection membrane system receptacle (3300); and an outlet (3400).
Patent NZ-614493-A (NZ)
Title: Methods of treating cancer using 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
Inventor: GANDHI ANITA
IPC: A61P35/00
Filed: 2012-03-09
Abstract: Provided are methods of treating cancers comprising the administration of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3- yl)-piperidine-2,6-dione, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof. In a preferred embodiment the compound is used to treat diffuse large B-cell lymphoma of the activated B-cell phenotype.
Patent NZ-615049-A (NZ)
Title: Wind turbine generator system and method for operating a wind turbine generator system
Inventor: BEEKMANN ALFRED
IPC: H02P9/04
Filed: 2012-03-23
Abstract: Disclosed is a method of controlling a wind power installation connected to an electric network having a generator with an aerodynamic rotor with an adjustable rotary speed. The wind power installation can be operated at an operating point which is optimum in relation to prevailing wind conditions at an optimum rotary speed. The wind power installation is operated for a transitional period of time or lastingly at a non-optimum operating point at a non-optimum rotary speed and the non-optimum rotary speed is higher than the optimum rotary speed. A first operating characteristic is stored for setting a respectively optimum operating speed and a second operating characteristic is used for controlling the wind power installation at the non-optimum rotary speed and the non-optimum rotary speed is set on the basis of the second operating characteristic at a part-load mode of operation. A higher rotary speed is set based on the non-optimum operating characteristic with the same output power as in the case of the corresponding optimum operating point.
Patent NZ-701459-A (NZ)
Title: Systems and methods for secure processing with embedded cryptographic unit
Inventor: SMITH MALCOLM RONALD
IPC: G06Q20/34
Filed: 2014-10-29
Abstract: A cryptographic processor system is disclosed. The system comprises a general purpose unit comprising a general purpose processor; and a cryptographic processing unit for cryptographic processing in conjunction with the general purpose processor. The cryptographic processing unit comprises a protected memory that stores a secret key and a user data block, wherein the user data block comprises a login block hash and a plurality of script hashes; and a cryptographic processor, wherein the general purpose processor is configured to provide an encrypted user data block and a script to the cryptographic processor. The cryptographic processor is configured to receive the encrypted user data block from the general purpose processor; decrypt the encrypted user data block based on the secret key to generate a user login block; hash the user login block to generate a user login block hash value; compare the user login block hash value to the login block hash, wherein the cryptographic processor is configured to access the plurality of script hashes based on the user login block hash value being a match of the login block hash; receive the script from the general purpose computer; hash the script to generate a received script hash value; compare the received script hash value to the plurality of script hashes; and execute the script to produce a script result based on the received script hash value matching one of the plurality of script hashes. Also disclosed is a cryptographic processing unit for cryptographic processing in conjunction with a general purpose processor and a method for cryptographic processing by a cryptographic processor of a cryptographic processing unit.
Patent NZ-702283-A (NZ)
Title: Inflatable medical devices
Inventor: TILSON ALEXANDER QUILLIN
IPC: A61M29/02
Filed: 2013-06-06
Abstract: An inflatable balloon for use in medical procedures includes a base balloon having a cylindrical section and a conical section and at least one circumferential fiber extending circumferentially around the conical section (see Fig 49C). The at least one circumferential fiber provides shape control of the base balloon upon inflation. The inflatable balloon includes a plurality of reinforcing strips in the conical section over the at least one circumferential fiber. Each reinforcing strip includes a plurality of fibers extending at an angle inclined relative to the at least one fiber. Each reinforcing strip is positioned a set circumferential distance away from a neighboring reinforcing strip. The reinforcing strips prevent the at least one circumferential fiber from falling or slumping down the tapered surface of the conical section.